Teva has joined forces with Prestige Biopharma, picking up exclusive rights for the supply and commercialization of the Singapore-based firm’s HD201 trastuzumab biosimilar in Teva’s native Israel.
The partnership, signed between Prestige BioPharma and Abic Marketing, which operates under the brand of Teva Israel, will leverage Teva’s...






